168 related articles for article (PubMed ID: 27011712)
1. Pharmacovigilance study of Ayurvedic medicine in Ayurvedic Teaching Hospital: A prospective survey study.
Ajanal MN; Nayak SU; Kadam AP; Prasad BS
Ayu; 2015; 36(2):130-7. PubMed ID: 27011712
[TBL] [Abstract][Full Text] [Related]
2. Knowledge, attitude, and practices toward ayurvedic medicine use among allopathic resident doctors: A cross-sectional study at a tertiary care hospital in India.
Gawde SR; Shetty YC; Pawar DB
Perspect Clin Res; 2013 Jul; 4(3):175-80. PubMed ID: 24010059
[TBL] [Abstract][Full Text] [Related]
3. Patterns of concomitant use of
Galib R; Dang P; Kumar V; Rana R; Yadav P; Prajapati PK
Ayu; 2020; 41(2):72-78. PubMed ID: 34908791
[TBL] [Abstract][Full Text] [Related]
4. Pharmacovigilance: Boon for the safety and efficacy of Ayuvedic formulations.
Chaudhary A; Singh N; Kumar N
J Ayurveda Integr Med; 2010 Oct; 1(4):251-6. PubMed ID: 21731371
[TBL] [Abstract][Full Text] [Related]
5. Development of Ayurveda - Tradition to trend.
Mukherjee PK; Harwansh RK; Bahadur S; Banerjee S; Kar A; Chanda J; Biswas S; Ahmmed SM; Katiyar CK
J Ethnopharmacol; 2017 Feb; 197():10-24. PubMed ID: 27633405
[TBL] [Abstract][Full Text] [Related]
6. Pattern of adverse drug reactions notified by spontaneous reporting in an Indian tertiary care teaching hospital.
Jose J; Rao PG
Pharmacol Res; 2006 Sep; 54(3):226-33. PubMed ID: 16781163
[TBL] [Abstract][Full Text] [Related]
7. Pharmacovigilance of herbal medicines: Concerns and future prospects.
Choudhury A; Singh PA; Bajwa N; Dash S; Bisht P
J Ethnopharmacol; 2023 Jun; 309():116383. PubMed ID: 36918049
[TBL] [Abstract][Full Text] [Related]
8. Adverse drug reaction and concepts of drug safety in Ayurveda: An overview.
Ajanal M; Nayak S; Prasad BS; Kadam A
J Young Pharm; 2013 Dec; 5(4):116-20. PubMed ID: 24563588
[TBL] [Abstract][Full Text] [Related]
9. Drug safety reports on complementary and alternative medicines (ayurvedic and homeopathic medicines) by a spontaneous reporting program in a tertiary care hospital.
Jose J; Rao PG; Kamath MS; Jimmy B
J Altern Complement Med; 2009 Jul; 15(7):793-7. PubMed ID: 19534607
[TBL] [Abstract][Full Text] [Related]
10. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: ashwagandha.
Ven Murthy MR; Ranjekar PK; Ramassamy C; Deshpande M
Cent Nerv Syst Agents Med Chem; 2010 Sep; 10(3):238-46. PubMed ID: 20528765
[TBL] [Abstract][Full Text] [Related]
11. Knowledge, attitude and practice towards Ayurveda among patients attending cardiology and neurology clinics at a tertiary care institute in India.
Sharma G; Sharma V; Mridula MK; Agrawal A; Ram A; Khuntia BK; Mohanty S; Dhanlika MJ; Lamo P; Pandey RM
Natl Med J India; 2023; 36(3):145-149. PubMed ID: 38692607
[TBL] [Abstract][Full Text] [Related]
12. Knowledge, attitude and practice towards pharmacovigilance among ayurveda physicians and teachers of Gujarat State: A cross sectional study.
Acharya R; Naik R; Rang S; Jani CA; Galib R
J Family Med Prim Care; 2022 Feb; 11(2):623-632. PubMed ID: 35360810
[TBL] [Abstract][Full Text] [Related]
13. Impact of pharmacovigilance on adverse drug reactions reporting in hospitalized internal medicine patients at Saudi Arabian teaching hospital.
Khan LM; Al-Harthi SE; Saadah OI; Al-Amoudi AB; Sulaiman MI; Ibrahim IM
Saudi Med J; 2012 Aug; 33(8):863-8. PubMed ID: 22886119
[TBL] [Abstract][Full Text] [Related]
14. Herbo mineral formulations (rasaoushadhies) of ayurveda an amazing inheritance of ayurvedic pharmaceutics.
Chaudhary A; Singh N
Anc Sci Life; 2010 Jul; 30(1):18-26. PubMed ID: 22557419
[TBL] [Abstract][Full Text] [Related]
15. Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital.
Geer MI; Koul PA; Tanki SA; Shah MY
J Pharmacol Toxicol Methods; 2016; 81():323-34. PubMed ID: 27109493
[TBL] [Abstract][Full Text] [Related]
16. Changing scenario for promotion and development of Ayurveda--way forward.
Mukherjee PK; Nema NK; Venkatesh P; Debnath PK
J Ethnopharmacol; 2012 Sep; 143(2):424-34. PubMed ID: 22885133
[TBL] [Abstract][Full Text] [Related]
17. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
[TBL] [Abstract][Full Text] [Related]
18. Product development and characterization of the Ayurvedic herbo-mineral-metallic compound- Hridayarnava Rasa.
Jagtap CY; Mishra AK; Nariya M; Shukla VJ; Prajapati PK
J Ayurveda Integr Med; 2024; 15(3):100886. PubMed ID: 38759538
[TBL] [Abstract][Full Text] [Related]
19. Ayurpharmacoepidemiology en Route to Safeguarding Safety and Efficacy of Ayurvedic Drugs in Global Outlook.
Debnath P; Banerjee S; Adhikari A; Debnath PK
J Evid Based Complementary Altern Med; 2017 Apr; 22(2):294-298. PubMed ID: 26721554
[TBL] [Abstract][Full Text] [Related]
20. Lead, mercury, and arsenic in US- and Indian-manufactured Ayurvedic medicines sold via the Internet.
Saper RB; Phillips RS; Sehgal A; Khouri N; Davis RB; Paquin J; Thuppil V; Kales SN
JAMA; 2008 Aug; 300(8):915-23. PubMed ID: 18728265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
